Background Efforts to reduce cesarean delivery rates to 12–15% have been undertaken worldwide. Special focus has been directed towards parturients who undergo a trial of labor after cesarean delivery to reduce the burden of repeated cesarean deliveries. Complication rates are lowest when a vaginal birth is achieved and highest when an unplanned cesarean delivery is…

Read More
Dr. Milana Frenkel-Morgenstern

Abstract Circulating tumor DNA (ctDNA) has recently emerged as a minimally invasive ‘liquid biopsy’ tool in precision medicine. ctDNA-genomic DNA fragments that are released into the bloodstream after the active secretion of microvesicles or tumor cell lysis-reflects tumor evolution and the genomic alterations present in primary and/or metastatic tumors. Notably, ctDNA analysis might allow the…

Read More